Durham, N.C. — Donald Kellerman, senior vice president for development and a member of the board at Inspire Pharmaceuticals, is leaving the company.
Inspire (Nasdaq: ISPH) said Kellerman is stepping down as of July 21 to take a position at another pharmaceutical firm. Kellerman has worked at Inspire since 1999.
A former executive at GlaxoSmithKline, Kellerman has been responsible for clinical and regulatory affairs at Inspire.
Inspire’s vice president for development is leaving firm
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- DataFlux, parent SAS partner for new data management solution
Posted 38 minutes ago - N.C. Biotech Center offers more grant information for researchers
Posted 58 minutes ago - Golden Pine licenses technology to launch fourth drug startup company
Updated at 11:09 a.m. - While energy producers plan ever taller towers, Wall Street crumbles
Updated at 11:00 a.m. - Silicon Valley exit feast – Celebrating eBay’s $945M buy of Bill Me Later
Posted at 7:37 a.m.
- DataFlux, parent SAS partner for new data management solution
-
- Next CED entrepreneurial training program begins Oct. 7
Posted Oct. 6 2:20 p.m. - Semiconductor startup drops interim name for siXis
Oct. 6, 2008 - Biolex Therapeutics closes on $60M in financing
Oct. 6, 2008 - What’s up with Apple ‘Brick’ project? Could be new way to build laptops
Oct. 6, 2008 - Entrepreneurs caught in a perfect storm of financial incompetence
Oct. 6, 2008
- Next CED entrepreneurial training program begins Oct. 7
More from wrallocaltechwire.com
Market Watch

